Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management Farhat Nasim16 Oct 2019 4:10 AM GMTNew Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine...
Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit Medical Dialogues Bureau12 Jun 2019 4:00 AM GMTRoche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details Farhat Nasim4 Jun 2019 12:14 PM GMTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
CDSCO Committee rejects proposal for additional Indications of Dapaglofizin Meghna A Singhania5 May 2019 7:22 AM GMTNew Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen Meghna A Singhania30 April 2019 4:46 AM GMTGlenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
Amazon Alexa to now help in health care; store BP measurement, book medical appointment, check prescription delivery Medical Dialogues Bureau8 April 2019 4:10 AM GMTAmazon announced that its Alexa-enabled devices can now handle customers' sensitive medical data. A new kit will allow approved developers to build...
Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark's SGLT2 Inhibitor Remogliflozin etabonate Meghna A Singhania31 March 2019 8:09 AM GMTNew Delhi: Mumbai-based Glenmark Pharmaceuticals Limited recently received the permission from the IND Committee of the Central Drugs Standard...
Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO Farhat Nasim26 March 2019 7:58 AM GMTNew Delhi: Paying heed to the safety updates of Sodium-Glucose Cotransporter-2 (SGLT2) including medicines such as Canagliflozin, Dapagliflozin,...